CytoSorbents Stock (NASDAQ: CTSO) stock price, news, charts, stock research, profile.
Open | $0.86 |
Close | $0.86 |
Volume / Avg. | 165.28K / 99.45K |
Day Range | 0.81 - 0.86 |
52 Wk Range | 0.70 - 4.29 |
Market Cap | $46.92M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 2.79% |
Days to Cover | 21.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytoSorbents (NASDAQ:CTSO) through any online brokerage.
Other companies in CytoSorbents’s space includes: Precision Optics Corp (NASDAQ:POCI), Pro-Dex (NASDAQ:PDEX), LENSAR (NASDAQ:LNSR), Modular Medical (NASDAQ:MODD) and Lucid Diagnostics (NASDAQ:LUCD).
There is no analysis for CytoSorbents.
CytoSorbents has a consensus price target of $2.67.
The stock price for CytoSorbents (NASDAQ: CTSO) is $0.864 last updated July 3, 2024 at 4:26 PM EDT.
There are no upcoming dividends for CytoSorbents.
CytoSorbents’s Q2 earnings are confirmed for Tuesday, July 30, 2024.
There is no upcoming split for CytoSorbents.
CytoSorbents is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.